Effect of Preload Reducing Therapy on Right Ventricular Size and Function in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy.
Sign Up to like & getrecommendations! Published in 2021 at "Heart rhythm"
DOI: 10.1016/j.hrthm.2021.03.018
Abstract: BACKGROUND Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is an important cause of sudden cardiac death in young people and athletes. Thus far, no treatment has proven to slow the progression of the disease. Preload reducing agents… read more here.
Keywords: ventricular cardiomyopathy; reducing agents; right ventricular; preload ... See more keywords